Diagnostics Company Named In Antibodies Test Accuracy Stock-Drop Suit

(June 29, 2020, 8:56 AM EDT) -- NEW YORK — A point-of-care diagnostics company and two of its senior executives misrepresented the accuracy of its antibody test used to determine current or past exposure to COVID-19 in violation...
To view the full article, register now.